Publication Name	World Journal of Nephrology
Manuscript ID	85930
Country	Iran

Received	2023-05-23 07:03
Peer-Review Started	2023-05-23 07:05
To Make the First Decision
Return for Revision	2023-08-16 06:03
Revised	2023-09-01 06:48
Second Decision	2023-09-18 05:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-09-25 08:31
Articles in Press	2023-09-25 08:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-18 01:10
Publish the Manuscript Online	2023-12-22 11:25

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Systematic Reviews
Article Title	Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Saeed Taheri
ORCID	Author(s) ORCID Number Saeed Taheri http://orcid.org/0000-0003-3034-0674
Funding Agency and Grant Number
Corresponding Author	Saeed Taheri, MD, Doctor, Department of Medicine, New Lahijan Scientific Foundation, #1 Kargar 19, 2nd ave, Lahijan 4415813166, Iran. taherimd@gmail.com
Key Words	Sodium glucose cotransporter 2 inhibitors; Cardiovascular; Renal outcome; efficacy; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction
Core Tip	Compared to placebo, treatment with Sodium glucose cotransporter 2 inhibitors improve cardiorenal outcomes in a broad range of disorders with significant heterogeneity in the subgroup of patients who are likely to benefit most from the treatment across their heart failure subtypes, New York Heart Associations classifications and ejection fraction levels. There are also adverse events associated with these drugs that deserve further research.
Publish Date	2023-12-22 11:25
Citation	Taheri S. Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis. World J Nephrol 2023; 12(5): 182-200
URL	https://www.wjgnet.com/2220-6124/full/v12/i5/182.htm
DOI	https://dx.doi.org/10.5527/wjn.v12.i5.182

Full Article (PDF)	WJN-12-182-with-cover.pdf
Full Article (Word)	WJN-12-182.docx
PRISMA 2009 Checklist	85930-PRISMA 2009 Checklist.pdf
Manuscript File	85930_Auto_Edited-LJH-JLW.docx
Answering Reviewers	85930-Answering reviewers.pdf
Audio Core Tip	85930-Audio core tip.m4a
Biostatistics Review Certificate	85930-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	85930-Conflict-of-interest statement.pdf
Copyright License Agreement	85930-Copyright license agreement.pdf
Supplementary Material	85930-Supplementary material.pdf
Peer-review Report	85930-Peer-review(s).pdf
Scientific Misconduct Check	85930-Bing-Liu JH-2.png
Scientific Misconduct Check	85930-CrossCheck.png
Scientific Editor Work List	85930-Scientific editor work list.pdf